Company		Revenue (₹ Cr)			Profit (₹ Cr)		Per share		8Q profit
Symbol	Sector	Reported	YoY	QoQ	Reported	YoY	EPS	vs consensus	Trend
SUNPHARMA Sun Pharmaceutical Industries Ltd	Healthcare	11,941	n/a	n/a	2,006	n/a	8.43	No estimate
AUROPHARMA Aurobindo Pharma Ltd	Healthcare	6,851	n/a	n/a	570	n/a	9.74	No estimate
DRREDDY Dr Reddys Laboratories Ltd	Healthcare	6,758	n/a	n/a	1,405	n/a	16.87	No estimate
CIPLA Cipla Ltd	Healthcare	6,329	n/a	n/a	998	n/a	12.33	No estimate
ZYDUSLIFE Zydus Lifesciences Ltd	Healthcare	5,140	n/a	n/a	1,134	n/a	10.74	No estimate
LUPIN Lupin Ltd	Healthcare	4,814	n/a	n/a	453	n/a	9.94	No estimate
BIOCON Biocon Ltd	Healthcare	3,423	n/a	n/a	149	n/a	0.84	No estimate
GLENMARK Glenmark Pharmaceuticals Ltd	Healthcare	3,036	n/a	n/a	173	n/a	5.31	No estimate
ALKEM Alkem Laboratories Ltd	Healthcare	2,968	n/a	n/a	288	n/a	23.98	No estimate
TORNTPHARM Torrent Pharmaceuticals Ltd	Healthcare	2,591	n/a	n/a	378	n/a	11.17	No estimate
MANKIND Mankind Pharma Ltd	Healthcare	2,579	n/a	n/a	494	n/a	12.15	No estimate
DIVISLAB Divis Laboratories Ltd	Healthcare	1,778	n/a	n/a	356	n/a	13.41	No estimate
PPLPHARMA Piramal Pharma Ltd	Healthcare	1,749	n/a	n/a	−99	n/a	−0.75	No estimate
JUBLPHARMA Jubilant Pharmova Ltd	Healthcare	1,587	n/a	n/a	6	n/a	0.40	No estimate
IPCALAB Ipca Laboratories Ltd	Healthcare	1,585	n/a	n/a	164	n/a	6.42	No estimate
EMCURE Emcure Pharmaceuticals Ltd	Healthcare	1,556	n/a	n/a	141	n/a	7.21	No estimate
APLLTD Alembic Pharmaceuticals Ltd	Healthcare	1,486	n/a	n/a	121	n/a	6.14	No estimate
ABBOTINDIA Abbott India Ltd	Healthcare	1,479	n/a	n/a	290	n/a	136.59	No estimate
GLAND Gland Pharma Ltd	Healthcare	1,209	n/a	n/a	194	n/a	11.79	No estimate
LAURUSLABS Laurus Labs Ltd	Healthcare	1,182	n/a	n/a	27	n/a	0.46	No estimate
NATCOPHARM Natco Pharma Ltd	Healthcare	1,140	n/a	n/a	420	n/a	21.42	No estimate
AJANTPHARM Ajanta Pharma Ltd	Healthcare	1,021	n/a	n/a	208	n/a	16.24	No estimate
GRANULES Granules India Ltd	Healthcare	986	n/a	n/a	48	n/a	1.98	No estimate
AKUMS Akums Drugs & Pharmaceuticals Ltd	Healthcare	970	n/a	n/a	−187	n/a	−13.16	No estimate
STAR Strides Pharma Science Ltd	Healthcare	930	n/a	n/a	−9	n/a	−0.79	No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals Ltd	Healthcare	896	n/a	up+17.6%	142	n/a	9.19	No estimate
SYNGENE Syngene International Ltd	Healthcare	808	n/a	n/a	93	n/a	2.32	No estimate
GLAXO Glaxosmithkline Pharmaceuticals Ltd	Healthcare	762	n/a	n/a	132	n/a	7.81	No estimate
DCAL Dishman Carbogen Amcis Ltd	Healthcare	723	n/a	n/a	17	n/a	1.08	No estimate
AARTIDRUGS Aarti Drugs Ltd	Healthcare	661	n/a	n/a	48	n/a	5.17	No estimate
WOCKPHARMA Wockhardt Ltd	Healthcare	644	n/a	n/a	−136	n/a	−9.30	No estimate
INDGN Indegene Ltd	Healthcare	608	n/a	n/a	68	n/a	3.08	No estimate
ALIVUS Alivus Life Sciences Ltd	Healthcare	578	n/a	n/a	135	n/a	11.05	No estimate
IOLCP IOL Chemicals & Pharmaceuticals Ltd	Healthcare	563	n/a	n/a	46	n/a	1.57	No estimate
FDC FDC Ltd	Healthcare	536	n/a	n/a	110	n/a	6.62	No estimate
PFIZER Pfizer Ltd	Healthcare	531	n/a	n/a	94	n/a	20.44	No estimate
SANOFI Sanofi India Ltd	Healthcare	515	n/a	n/a	123	n/a	53.43	No estimate
MARKSANS Marksans Pharma Ltd	Healthcare	500	n/a	n/a	70	n/a	1.52	No estimate
ERIS ERIS Lifesciences Ltd	Healthcare	467	n/a	n/a	94	n/a	6.98	No estimate
AARTIPHARM Aarti Pharmalabs Ltd	Healthcare	458	n/a	n/a	47	n/a	5.20	No estimate
INDOCO Indoco Remedies Ltd	Healthcare	426	n/a	n/a	24	n/a	2.65	No estimate
UNICHEMLAB Unichem Laboratories Ltd	Healthcare	423	n/a	n/a	−1	n/a	−0.10	No estimate
MOREPENLAB Morepen Laboratories Ltd	Healthcare	401	n/a	n/a	15	n/a	0.29	No estimate
CAPLIPOINT Caplin Point Laboratories Ltd	Healthcare	395	n/a	n/a	104	n/a	13.62	No estimate
NECLIFE Nectar Lifescience Ltd	Healthcare	394	n/a	n/a	2	n/a	0.08	No estimate
HIKAL Hikal Ltd	Healthcare	388	n/a	n/a	7	n/a	0.56	No estimate
NEULANDLAB Neuland Laboratories Ltd	Healthcare	363	n/a	n/a	62	n/a	48.23	No estimate
COHANCE Cohance Lifesciences Ltd	Healthcare	348	n/a	n/a	121	n/a	4.74	No estimate
VIYASH Viyash Scientific Ltd	Healthcare	333	n/a	n/a	−35	n/a	−1.40	No estimate
POLYMED Poly Medicure Ltd	Healthcare	321	n/a	n/a	63	n/a	6.54	No estimate
INDSWFTLAB Ind-Swift Laboratories Ltd	Healthcare	310	n/a	n/a	17	n/a	2.92	No estimate
PGHL Procter & Gamble Health Ltd	Healthcare	301	n/a	n/a	30	n/a	17.96	No estimate
ASTRAZEN Astrazeneca Pharma India Ltd	Healthcare	295	n/a	n/a	54	n/a	21.54	No estimate
SHILPAMED Shilpa Medicare Ltd	Healthcare	260	n/a	n/a	1	n/a	0.07	No estimate
INNOVACAP Innova Captab Ltd	Healthcare	233	n/a	n/a	18	n/a	3.66	No estimate
CONCORDBIO Concord Biotech Ltd	Healthcare	195	n/a	n/a	48	n/a	4.63	No estimate
GUFICBIO Gufic BioSciences Ltd	Healthcare	195	n/a	n/a	21	n/a	2.13	No estimate
ORCHPHARMA Orchid Pharma Ltd	Healthcare	183	n/a	n/a	9	n/a	1.85	No estimate
BI Bilcare Ltd	Healthcare	182	n/a	n/a	−13	n/a	−3.36	No estimate
BLUEJET Blue Jet Healthcare Ltd	Healthcare	180	n/a	n/a	44	n/a	2.54	No estimate
ANUHPHR Anuh Pharma Ltd	Healthcare	161	n/a	n/a	12	n/a	1.17	No estimate
BLISSGVS Bliss GVS Pharma Ltd	Healthcare	160	n/a	n/a	14	n/a	1.41	No estimate
ACUTAAS Acutaas Chemicals Ltd	Healthcare	154	n/a	n/a	22	n/a	2.71	No estimate
INDSWFTLTD Ind-Swift Ltd(Merged)	Healthcare	149	up+56.8%	up+40.6%	2	n/a	0.44	No estimate
RPGLIFE RPG Life Sciences Ltd	Healthcare	148	n/a	n/a	22	n/a	13.36	No estimate
ADVENZYMES Advanced Enzyme Technologies Ltd	Healthcare	147	n/a	n/a	29	n/a	2.58	No estimate
WANBURY Wanbury Ltd	Healthcare	146	n/a	n/a	5	n/a	1.43	No estimate
WINDLAS Windlas Biotech Ltd	Healthcare	145	n/a	n/a	12	n/a	5.80	No estimate
LINCOLN Lincoln Pharmaceuticals Ltd	Healthcare	136	n/a	n/a	19	n/a	9.49	No estimate
SMSPHARMA SMS Pharmaceuticals Ltd	Healthcare	135	n/a	n/a	9	n/a	1.10	No estimate
SUPRIYA Supriya Lifescience Ltd	Healthcare	132	n/a	n/a	29	n/a	3.54	No estimate
BAJAJHCARE Bajaj Healthcare Ltd	Healthcare	130	n/a	n/a	−48	n/a	−17.47	No estimate
PANACEABIO Panacea Biotec Ltd	Healthcare	129	n/a	n/a	11	n/a	1.79	No estimate
Tonira Pharma Ltd(merged)	Healthcare	122	n/a	down−9.0%	15	n/a	2.38	No estimate
KOPRAN Kopran Ltd	Healthcare	117	n/a	n/a	3	n/a	0.57	No estimate
Anus Laboratories Ltd	Healthcare	98	n/a	down−61.6%	−4	n/a	−0.20	No estimate
THEMISMED Themis Medicare Ltd	Healthcare	97	n/a	n/a	18	n/a	1.98	No estimate
VENUSREM Venus Remedies Ltd	Healthcare	95	n/a	n/a	1	n/a	0.88	No estimate
ALBERTDAVD Albert David Ltd	Healthcare	92	n/a	n/a	23	n/a	41.16	No estimate
Emergy Phaarma Ltd	Healthcare	92	n/a	up+122.7%	−9	n/a	−9.02	No estimate
NOVARTIND Novartis India Ltd	Healthcare	91	n/a	n/a	20	n/a	8.21	No estimate
HESTERBIO Hester Biosciences Ltd	Healthcare	88	n/a	n/a	7	n/a	6.90	No estimate
MANGALAM Mangalam Drugs and Organics Ltd	Healthcare	87	n/a	n/a	−10	n/a	−6.03	No estimate
SIGACHI Sigachi Industries Ltd	Healthcare	85	n/a	n/a	11	n/a	0.35	No estimate
FERMENTA Fermenta Biotech Ltd	Healthcare	82	n/a	n/a	2	n/a	0.62	No estimate
VIMTALABS Vimta Labs Ltd	Healthcare	82	n/a	n/a	12	n/a	2.63	No estimate
AMRUTANJAN Amrutanjan Health Care Ltd	Healthcare	78	n/a	n/a	7	n/a	2.40	No estimate
HALEOSLABS Haleos Labs Limited	Healthcare	75	n/a	n/a	−4	n/a	−5.95	No estimate
BALPHARMA Bal Pharma Ltd	Healthcare	70	n/a	n/a	0	n/a	0.05	No estimate
BPLPHARMA Bharat Parenterals Ltd	Healthcare	70	n/a	n/a	7	n/a	13.02	No estimate
NGLFINE NGL Fine Chem Ltd	Healthcare	69	n/a	n/a	8	n/a	12.64	No estimate
ZIMLAB Zim Laboratories Ltd	Healthcare	67	n/a	n/a	0	n/a	0.05	No estimate
KPL Kwality Pharmaceuticals Ltd	Healthcare	67	n/a	n/a	5	n/a	5.22	No estimate
BALAXI Balaxi Pharmaceuticals Ltd	Healthcare	66	n/a	n/a	−41	n/a	−8.07	No estimate
FREDUN Fredun Pharmaceuticals Ltd	Healthcare	62	n/a	n/a	2	n/a	1.75	No estimate
JAGSNPHARM Jagsonpal Pharmaceuticals Ltd	Healthcare	60	n/a	n/a	7	n/a	1.14	No estimate
SYNCOMF Syncom Formulations (India) Ltd	Healthcare	59	n/a	n/a	4	n/a	0.05	No estimate
SAMRATPHARMACHEMLTD	Healthcare	57	n/a	n/a	1	n/a	1.97	No estimate
ANGLIFESCIENCESINDIALTD	Healthcare	56	n/a	n/a	2	n/a	1.34	No estimate
VALIANTLAB Valiant Laboratories Ltd	Healthcare	51	n/a	n/a	4	n/a	1.05	No estimate

About Q1 FY24 earnings data

When are Q1 FY24 results announced?

Q1 FY24 covers the Apr–Jun 2023 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.

Why do some Q1 FY24 growth figures show "n/a" instead of a percentage?

Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.

Does the beat/miss verdict cover every company?

No analyst consensus was available for Q1 FY24, so no beat/miss verdict is shown. Revenue and profit growth are taken from reported results and cover every company in the table.

What counts as an in-line result rather than a beat or a miss?

Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.

Are the figures consolidated or standalone?

Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.

What does the 8-quarter trend line show?

Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.

How do I find only the companies that beat estimates in Q1 FY24?

Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.